Background: Test weighing, or weighing the infant before and after breastfeeding to assess milk intake, in which weight gain in grams is converted equally to volume of intake in milliliters, is a controversial topic in the literature. This study was initiated to identify variables that impact test weights and to develop an accurate test weighing technique for preterm and high-risk hospitalized infants.

Methods: Test weights were performed on a sample of hospitalized high-risk infants with and without leads who were bottle- or nasogastric-fed. Volume consumed was compared to weight gain to determine whether the developed technique was accurate.

Results: In each group, with or without leads, only one measure of actual intake versus test weight result was found outside the confidence limits (95%), and only one measure was found outside the clinically acceptable difference of +/-5 g. Correlation coefficient (r(2)) values of weight gain by test weight to volume of intake were 0.998 for infants without leads and 0.997 for infants with leads.

Conclusions: The data from this study support the use of this test weighing technique as an accurate, objective assessment of the measurement of breastmilk intake after a breastfeeding session, thus allowing medical decisions regarding supplementation to be based on objective data rather than inaccurate clinical indices of the quality of infant feedings at the breast.

Download full-text PDF

Source
http://dx.doi.org/10.1089/bfm.2008.0125DOI Listing

Publication Analysis

Top Keywords

test weighing
16
weighing technique
12
weight gain
12
test
8
accurate test
8
technique preterm
8
preterm high-risk
8
high-risk hospitalized
8
volume intake
8
test weights
8

Similar Publications

Drug Development.

Alzheimers Dement

December 2024

Mayo Clinic, Rochester, MN, USA.

Recent breakthrough findings in clinical trials on amyloid-lowering therapies have led to the approval of these drugs for the treatment of amyloid- positive elderly individuals who show symptoms of mild cognitive impairment and mild dementia. The next frontier is the testing the efficacy of treatments for secondary prevention of AD dementia. Phase III trials in asymptomatic AD are already under way, raising a host of novel questions on the sequelae of trial participation such as the emotional and social repercussions of biomarker disclosure, understanding the risk of side effects and eventually weighing the risk-benefit ratio of amyloid-lowering treatment.

View Article and Find Full Text PDF

Background: Irisin is an exercise-induced myokine that elicits beneficial effects of exercise in fat, bone, and the brain. Previous work suggests that extracellular heat shock protein 90a (Hsp90a) mediates irisin-receptor interaction in bone and fat. Despite this, it remains unclear if Hsp90a is necessary for irisin signaling in the brain.

View Article and Find Full Text PDF

Dementia Care Practice.

Alzheimers Dement

December 2024

Mayo Clinic, Rochester, MN, USA.

Aging adults worldwide are presenting to the emergency department with acute and subacute illness and injury confounded by often unrecognized cognitive impairment, including dementia and delirium. Conveying medical information and weighing various diagnostic and therapeutic approaches during times of emergency is difficult for all aging adults. In adult ED populations without dementia, communication is imperfect with incomplete recollection of test results, presumptive diagnoses, prescriptions, and follow-up recommendations.

View Article and Find Full Text PDF

The main challenges to the widespread clinical application of three-dimensional (3D)-printed customized trays include cost and time limitations. This study examined how changing the internal structure of 3D-printed materials used for customized trays affects flexural strength (FS), flexural modulus (FM), manufacturing time, and material weight. Specimens (64 × 10 × 3.

View Article and Find Full Text PDF

Objective: To determine the effect of the administration of oral gabapentin (20 mg/kg) and trazodone (8 mg/kg) on the MAC of isoflurane in dogs.

Methods: 6 adult dogs (3 castrated males and 3 spayed females), aged 13.3 ± 1.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!